Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04997473 · ClinicalTrials.gov registry record · NA

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

A NA study of Obesity and Stem Cell Transplant, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04997473 is a NA study of Obesity and Stem Cell Transplant that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04997473, a NA study of Obesity and Stem Cell Transplant, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.

Interventions

  • BEHAVIORAL W8L2G mobile health (mHealth) app

Study Locations (1)

California

  • UCLA Mattel Children's Hospital - Los Angeles

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-08-15
Est. Completion 2027-01-09
Phase NA

What the Registry Record Tells You About NCT04997473

The ClinicalTrials.gov registry entry for NCT04997473 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which W8L2G mobile health (mHealth) app is the first listed.

NCT04997473 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04997473 about?

NCT04997473 is a clinical study titled "Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients". Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addicti...

What is the current status of trial NCT04997473?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-08-15. Estimated completion is 2027-01-09.

What conditions does trial NCT04997473 study?

This clinical trial studies the following conditions: Obesity, Stem Cell Transplant.

What interventions are being tested in trial NCT04997473?

The interventions under investigation include: W8L2G mobile health (mHealth) app (BEHAVIORAL).

Who is sponsoring clinical trial NCT04997473?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04997473 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.